ECOG E3108- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Objective

This phase II trial is studying how well tamoxifen citrate works in patients with metastatic or recurrent breast cancer. 

http://clinicaltrials.gov/ct2/show/NCT01124695

Location:

Essentia Health Brainerd, Essentia Health Duluth, Essentia Health Fargo

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 07/09/2012

Research Study Categories

  • Adult Studies

Specialty

  • Cancer
  • Breast Cancer
Contact
Cancer Clinical Trials at 218-786-3308